文献速递肝胆胰外科围术期管理与 ERAS

手术方式对胰腺导管腺癌切除术后早期恢复既定肿瘤治疗的影响

Effect of surgical approach on early return to intended oncologic therapy after resection for pancreatic ductal adenocarcinoma.
PubMed 文献 · Surg Endosc · 2024-07-10

该回顾性队列研究采用1:2倾向性评分匹配,比较机器人或开放胰腺切除术(远端胰腺切除术或胰十二指肠切除术)治疗胰腺导管腺癌患者,在机器人胰腺切除术开展最初3年内的早期恢复既定肿瘤治疗(RIOT)情况。匹配队列包括26例机器人胰腺切除术患者和52例开放胰腺切除术患者。机器人组早期RIOT率(73.1%)高于开放组(44.2%;P=0.018),多变量分析显示机器人入路与早期RIOT相关(比值比3.54;95%CI 1.08-11.62;P=0.038),手术入路未影响晚期RIOT(比值比3.21;95%CI 0.71-14.38;P=0.128)。

要点

  • 机器人胰腺切除术组早期RIOT率73.1%,高于开放组的44.2%(P=0.018)。
  • 多变量分析显示机器人入路与早期RIOT独立相关(OR=3.54;95%CI 1.08-11.62)。
  • 手术入路对晚期RIOT无显著影响(OR=3.21;95%CI 0.71-14.38;P=0.128)。

核心结论

  • 与开放胰腺切除术相比,机器人胰腺切除术未延迟RIOT,且早期RIOT的 odds 增加,支持机器人胰腺切除术项目实施期间的肿瘤学安全性。

研究设计与样本

  • 回顾性队列研究,采用1:2倾向性评分匹配,比较机器人或开放胰腺切除术(远端胰腺切除术或胰十二指肠切除术)治疗PDAC患者,时间为机器人胰腺切除术开展最初3年(2018年1月至2021年12月)。
  • 匹配队列包括26例机器人胰腺切除术患者和52例开放胰腺切除术患者。

主要发现

  • 机器人组和开放组接受辅助化疗的比例分别为96.2%和78.9%。
  • 机器人组早期RIOT率为73.1%,开放组为44.2%(P=0.018)。
  • 多变量分析中,机器人入路与早期RIOT相关(比值比3.54;95%CI 1.08-11.62;P=0.038)。
  • 手术入路未影响晚期RIOT(比值比3.21;95%CI 0.71-14.38;P=0.128)。

关键数值与推荐

  • 早期RIOT定义为术后8周内开始辅助化疗。
  • 晚期RIOT定义为术后12周内开始辅助化疗。

临床怎么用

  • 在机器人胰腺切除术开展初期,选择机器人入路可能有助于PDAC患者更早启动辅助化疗。
  • 机器人胰腺切除术未延迟RIOT,支持其在该情境下的肿瘤学安全性。

局限性

  • 回顾性队列研究,样本量较小(匹配后78例)。
  • 仅反映单中心机器人胰腺切除术开展最初3年的经验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although robotic pancreatectomy may facilitate an earlier functional recovery, the impact of a robotic pancreatectomy program during its early experience on the timing of return to intended oncologic therapy (RIOT) after surgery is unknown. METHODS: In this retrospective cohort study, we used propensity score matching with a 1:2 ratio to compare patients who underwent robotic or open surgery (distal pancreatectomy or pancreatoduodenectomy) for pancreatic ductal adenocarcinoma (PDAC) during the first 3 years of our robotic pancreatectomy experience (January 2018-December 2021). Generalized estimating equations modeling was used to evaluate the effect of surgical approach on early RIOT, defined as adjuvant chemotherapy initiation within 8 weeks after surgery, and late RIOT, defined as initiation within 12 weeks after surgery. RESULTS: The matched cohort included 26 patients who underwent robotic pancreatectomy and 52 patients who underwent open pancreatectomy. Rates of receipt of adjuvant chemotherapy were 96.2% and 78.9%, respectively. Rate of early RIOT in the robotic group (73.1% was higher than that in the open group (44.2%; P = 0.018). In multivariable analysis, a robotic approach was associated with early RIOT (odds ratio, 3.54; 95% confidence interval 1.08-11.62; P = 0.038). Surgical approach did not impact late RIOT (odds ratio, 3.21; 95% confidence interval 0.71-14.38; P = 0.128). CONCLUSIONS: Compared with open pancreatectomy, robotic pancreatectomy did not delay RIOT. In fact, odds of early RIOT were increased, which supports the oncological safety of our robotic pancreatectomy program during its implementation.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lu PW, Lyu HG, Prakash LR, et al. Effect of surgical approach on early return to intended oncologic therapy after resection for pancreatic ductal adenocarcinoma. Surg Endosc. 2024. PMID: 38987482. doi:10.1007/s00464-024-11022-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。